SCHEMBL7041950

SCHEMBL7041950

FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C1CCCCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9486545 1.00
SCHEMBL9485880 0.98
SCHEMBL7043388 0.94
SCHEMBL7045770 0.94
SCHEMBL7043595 0.94
SCHEMBL3880695 0.92
SCHEMBL104183 0.92
SCHEMBL6715403 0.86
SCHEMBL426888 0.85
SCHEMBL2268394 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220379559-A1 RESIN CASSETTES WITH LIQUID INHIBITOR BEDS TO MINIMIZE GHOSTING DURING ADDITIVE MANUFACTURING CARBON INC (US) 2022-12-01 US disclosed
US-11446871-B2 Resin cassettes with liquid inhibitor beds to minimize ghosting during additive manufacturing CARBON, INC. (US) 2022-09-20 US disclosed
US-20210094231-A1 RESIN CASSETTES WITH LIQUID INHIBITOR BEDS TO MINIMIZE GHOSTING DURING ADDITIVE MANUFACTURING CARBON INC (US) 2021-04-01 US disclosed
EP-1295602-A1 OXYGEN-CONTAINING OPHTHALMIC COMPOSITION ROHTO PHARMACEUTICAL CO., LTD. (JP) 2003-03-26 EP disclosed
US-20020164379-A1 Oxygen-containing ophthalmic composition ROHTO PHARMACEUTICAL CO., LTD. (JP) 2002-11-07 US disclosed
US-5374243-A Oxygen permeable bag containing oxygen-transporting perfluorochemical for providing oxygen internally to mammals ALPHA THERAPEUTIC CORPORATION (US) 1994-12-20 US disclosed
EP-0201275-B1 Pharmaceutical compositions for treating metastasis of cancerous tumors ALPHA THERAPEUTIC CORP (US) 1993-12-08 EP disclosed
US-5262442-A Fluosol for injection for oxygen transport ALPHA THERAPEUTIC CORPORATION (US) 1993-11-16 US disclosed
EP-0548601-A1 Process for rapid thawing and storage of frozen fluorocarbon emulsion, and resultant product ALPHA THERAPEUTIC CORPORATION (US) 1993-06-30 EP disclosed
US-5180676-A Suspension of cells in a liquid fluorocarbon having dissolved oxygen in a culture medium TEIJIN LIMITED (JP) 1993-01-19 US disclosed
WO-1992022202-A1 THROMBOLYTIC AND PERFLUOROCHEMICAL TREATMENT FOR MYOCARDIAL INFRACTION ALPHA THERAPEUTICS CORPORATION (US) 1992-12-23 WO disclosed
EP-0164813-B1 METHOD OF CULTIVATING ANIMAL OR PLANT CELLS TEIJIN LIMITED (JP) 1991-10-09 EP disclosed
US-4815446-A ADMINISTERING PERFLUOROCARBON EMULSION AND OXYGEN ALPHA THERAPEUTIC CORPORATION (US) 1989-03-28 US disclosed
EP-0201275-A1 Pharmaceutical compositions for treating metastasis of cancerous tumors ALPHA THERAPEUTIC CORPORATION (US) 1986-11-12 EP disclosed
EP-0164813-A2 Method of cultivating animal or plant cells TEIJIN LIMITED (JP) 1985-12-18 EP disclosed
EP-0033402-B1 PERFUSATE FOR PRESERVING ORGAN TO BE TRANSPLANTED AND PRESERVING METHOD The Green Cross Corporation (JP) 1983-09-07 EP disclosed
US-4285928-A AN EMULSION OF AN X-RAY CONTRAST AGENT AND A MIXTURE OF PERFLUORO COMPOUNDS HAVING OXYGEN-CARRYING ABILITIES Wada, Juro (JP) 1981-08-25 US disclosed
US-4252827-A PERFLUORODECALIN AND PERFLUOROTRIPROPYLAMINE; ETHYLENE OXIDE-PROPYLENE OXIDE COPOLYMER; PHOSPHOLIPID; FATTY ACID, SALT OR MONOGLYCERIDE THE GREEN CROSS CORPORATION (JP) 1981-02-24 US disclosed
US-4186253-A RINGER'S SOLUTION WITH INCREASED POTASSIUM ION, ALBUMIN, PERFLUOROCARBON COMPOUND, EMULSIFIER THE GREEN CROSS CORPORATION (JP) 1980-01-29 US disclosed